Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong
· Delayed Price · Currency is HKD 45.72
+1.02 (2.28%)
At close: Dec 5, 2025
Sunshine Lake Pharma Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 26,365 | 8,412 | 8,351 | 5,720 | 5,368 | 7,770 | Upgrade
|
| Market Cap Growth | 230.70% | 0.74% | 46.00% | 6.56% | -30.92% | -60.53% | Upgrade
|
| Enterprise Value | 27,245 | 9,289 | 9,299 | 9,130 | 7,738 | 7,962 | Upgrade
|
| Last Close Price | 45.72 | 32.84 | 32.60 | 22.33 | 20.95 | 30.33 | Upgrade
|
| PE Ratio | 20.65 | 16.38 | 3.80 | 66.05 | - | 7.79 | Upgrade
|
| PS Ratio | 6.65 | 2.12 | 1.20 | 1.35 | 4.79 | 2.79 | Upgrade
|
| PB Ratio | 2.91 | 0.93 | 0.96 | 0.83 | 0.73 | 1.28 | Upgrade
|
| P/TBV Ratio | 3.40 | 1.08 | 1.17 | 1.71 | 1.19 | 2.00 | Upgrade
|
| P/FCF Ratio | - | - | 5.70 | 4.48 | - | 21.43 | Upgrade
|
| P/OCF Ratio | 277.07 | 88.41 | 4.53 | 2.98 | - | 5.04 | Upgrade
|
| EV/Sales Ratio | 6.88 | 2.34 | 1.34 | 2.16 | 6.90 | 2.86 | Upgrade
|
| EV/EBITDA Ratio | 24.04 | 8.29 | 2.66 | 11.68 | - | 7.06 | Upgrade
|
| EV/EBIT Ratio | 38.25 | 13.05 | 3.03 | 25.02 | - | 8.04 | Upgrade
|
| EV/FCF Ratio | -29.13 | - | 6.35 | 7.15 | - | 21.96 | Upgrade
|
| Debt / Equity Ratio | 0.26 | 0.26 | 0.33 | 0.63 | 0.53 | 0.59 | Upgrade
|
| Debt / EBITDA Ratio | 2.10 | 2.10 | 0.82 | 5.46 | - | 3.15 | Upgrade
|
| Debt / FCF Ratio | - | - | 1.96 | 3.38 | - | 9.86 | Upgrade
|
| Asset Turnover | 0.30 | 0.30 | 0.51 | 0.33 | 0.09 | 0.24 | Upgrade
|
| Inventory Turnover | 1.76 | 1.76 | 3.62 | 3.02 | 1.31 | 1.20 | Upgrade
|
| Quick Ratio | 1.29 | 1.29 | 0.87 | 0.46 | 1.36 | 0.64 | Upgrade
|
| Current Ratio | 1.77 | 1.77 | 1.40 | 1.01 | 1.66 | 0.78 | Upgrade
|
| Return on Equity (ROE) | 5.87% | 5.87% | 26.50% | 0.81% | -10.57% | 17.22% | Upgrade
|
| Return on Assets (ROA) | 3.32% | 3.32% | 14.16% | 1.80% | -2.85% | 5.35% | Upgrade
|
| Return on Capital (ROIC) | 3.93% | 3.93% | 17.07% | 2.11% | -3.30% | 6.61% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.00% | 7.00% | 33.20% | 4.60% | -4.90% | 15.40% | Upgrade
|
| Earnings Yield | 1.95% | 6.11% | 26.29% | 1.51% | -13.44% | 12.83% | Upgrade
|
| FCF Yield | -3.55% | -11.12% | 17.54% | 22.33% | -23.30% | 4.67% | Upgrade
|
| Dividend Yield | 12.87% | - | - | - | - | 1.49% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 26.21% | Upgrade
|
| Buyback Yield / Dilution | - | - | - | - | 20.42% | -9.51% | Upgrade
|
| Total Shareholder Return | 12.87% | - | - | - | 20.42% | -8.03% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.